FaDièse
VC Fund
Paris, France
FaDièse is a private equity firm that focuses on investments in digital, life sciences, and industrial technologies.An investment committee comprised of shareholders, company managers themselves, makes investment decisions and are supported by two permanent staff who provide the back office. Shareholders alongside business angels, investors aredistinguished from capital consolidation (France Investissement, SCOR, AVIVA). This business model unique among venture capital funds and Business Angels network, allows us to invest at a rate of 7 to 8 companies per year.
- Total investments:
- 22
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries FaDièse invests in
Stages FaDièse invests in
Countries FaDièse invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $446k–$5.3M
- Series A
- $1.3M–$1.7M
- Venture - Series Unknown
- $1.2M–$12M
Investment Focus
Industry
- Software 6 (27%)
- Internet 4 (18%)
- Information Technology 4 (18%)
- SaaS 3 (14%)
- E-Commerce 3 (14%)
Stage
- Seed 7 (32%)
- Venture - Series Unknown 6 (27%)
- Series A 4 (18%)
- Funding Round 2 (9%)
- Series B 1 (5%)
Country
- France 17 (77%)
- United States 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
| CEO | Total investments: 0 | Find email | ||
Luc Dohan
Investment Director "Industrial Technologies"
|
Investment Director "Industrial Technologies" | Total investments: 0 | Find email | |
Michel Datchary
Director of Investment "digital"
|
Director of Investment "digital" | Total investments: 0 | Find email | |
Thierry Bardon
Director of Investment
|
Director of Investment | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Phaxiam is a clinical-stage biopharmaceutical company focused on developing innovative bacteriophage-based therapies to combat antimicrobial resistance. Specializing in the field of phage therapy, Phaxiam's research and development efforts are aimed at creating antibacterial treatments that utilize bacteriophage viruses, or phages, to targetand eliminate resistant bacterial infections in humans. These infections are a growing concern in healthcare due to their ability to resist traditional antibiotics. By harnessing the specificity and effectiveness of phages, Phaxiam is working towards providing new solutions for serious bacterial infections that are difficult to treat with existing antibiotics. | $8.4M / Post-IPO Equity / Jun 12, 2024 | ||
| Nannybag allow travelers from all over the world to store their luggage in partner shops, restaurants, bars and hotels (called Nannies). Our network is in service in more than 160+ cities in 16 countries around the world, some of our partners are working overnight to keep your bags (24/7). Easy to use before checking-in or afterchecking-out from your Airbnb, when you're in transit, after business appointments or before visiting a museum. All bookings are insured by AXA Insurance and payment 100% secured online. 6€ for the first 24h, then 4€ for additional 24h everywhere in EU. £6 for the first 24h, then £4 for additional 24h in the UK. $6 for the first 24h, then $4 for the additional 24h in the US. For security reasons and to prevent deposit points from receiving unexpected and unregistered customers on Nannybag, the exact address of the deposit is communicated only upon completed online booking. This way you are guaranteed not to have a line :) Network operating in New York, Paris, Berlin, London, Amsterdam, Madrid, Barcelona, Lisboa, Roma, and many more Feel Free on www.nannybag.com! | $2.1M / Seed / Jan 28, 2020 | ||
| UPFACTOR is a Independent advisory body, specialist in large-scale detection of aerial land potential. Transversal expertise. (architecture, engineering, law). | $2.8M / Seed / Dec 04, 2019 | ||
| Lucky Cart is the pioneer of promotional intelligence and has created a Promotion Management Platform allowing retailers and suppliers to optimise their promotional investments through advanced personalisation and performance measurement.Their mission is to deliver the best performance for your promotional campaigns.Founded in 2011, Lucky Cartoperates in the United Kingdom, Germany, France, Austria, the Netherlands and Belgium on behalf of more than 150 customers including Feelunique, Cdiscount, Intermarché, The Body Shop, Franprix, La Redoute and Best Western.Lucky Cart is backed by industry leading technology investors Partech Ventures, KIMA Ventures and Edenred Capital Partners. | $4.1M / Venture - Series Unknown / Dec 13, 2018 | ||
| Gymlib was started in 2014 by two entrepreneurs with a passion for sport: Sébastien Bequart and Mohamed Tazi. Grégoire Veron joined them as a Late Co-Founder in 2016. Their initial goal was to offer unlimited sports activities to individuals: an affordable, no-obligation, transparent and comprehensive package.Since 2017, they have extended theirrange of services in order to address the world of business. They work with companies to help them in the areas of commitment and preventative healthcare for employees and also employer branding. Their package has already won the custom of hundreds of businesses in the start-up sector, as well as major groups listed in the CAC 40 index. | $11.9M / Venture - Series Unknown / May 14, 2018 | ||
| Medsenic is a privately held company that manufactures drugs for the treatment of autoimmune diseases. | $2.5M / Venture - Series Unknown / Feb 06, 2018 | ||
| Pherecydes Pharma operator of an innovative biotechnologies company created to develop personalized phage therapy to treat bacterial infections. The company develops bacteriophages against infections and launched multicenter European phage therapy trial to evaluate phage therapy on infected burn wounds, recognize bacterial target attached to itsouter membrane, inject genetic material and reproduce in the host to make new phages that get out and repeat the same cycle, enabling doctors to detect and treat people and their environment against a large range of biothreat agents, including multi-resistant, emergent or previously uncharacterized bacteria. | $10.7M / Series B / Jan 16, 2018 | ||
| M-OTION Engineering is a French start-up that has developed an anti-dive technology for mtb and motorcycle forks. Starting with high end MTB forks distributed under the brand Motion Ride, Motion company's aim is tobecome within 5 years a recognized brand of technological innovations in sport and motorcycle industries. | $1.2M / Venture - Series Unknown / Oct 30, 2017 | ||
| Gymlib was started in 2014 by two entrepreneurs with a passion for sport: Sébastien Bequart and Mohamed Tazi. Grégoire Veron joined them as a Late Co-Founder in 2016. Their initial goal was to offer unlimited sports activities to individuals: an affordable, no-obligation, transparent and comprehensive package.Since 2017, they have extended theirrange of services in order to address the world of business. They work with companies to help them in the areas of commitment and preventative healthcare for employees and also employer branding. Their package has already won the custom of hundreds of businesses in the start-up sector, as well as major groups listed in the CAC 40 index. | $3.4M / Seed / Jul 06, 2017 | ||
| TestWe propose a software for students that is secure, offline and comfortable for students so that they can focus on their argumentation without the pressure of time. Most importantly, students can take their exams on their own device, that’s the BYOD.We developed a headache-free platform for faculty and professors, so they can create and gradecopies on any device, adding as much multimedia content as they want. With our solution, institutions save up to 2,000 hours of work per year and up to 66% on operational costs. | $1.5M / Series A / Jul 01, 2017 | ||
| See all 22 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does FaDièse invest in?
FaDièse invests primarily in Software, Internet and Information Technology startups, most often at Seed and Venture - Series Unknown stage. Most of the 22 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is FaDièse's check size?
FaDièse typically joins rounds of $446k–$5.3M at Seed, $1.3M–$1.7M at Series A and $1.2M–$12M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds FaDièse participates in.
How do I contact FaDièse?
Public channels for FaDièse include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at FaDièse?
The team at FaDièse includes Isabelle De Baillenx (CEO), Luc Dohan (Investment Director "Industrial Technologies") and Michel Datchary (Director of Investment "digital"). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
